[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100314839":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":16,"studyPopulation":17,"armGroups":13,"interventions":18,"overallOfficials":23,"centralContacts":27,"locations":33,"responsibleParty":56,"collaborators":13,"id":58,"slug":13,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":12,"studyType":71,"phases":13,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":36,"whyStopped":13,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Inova Health Care Services","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Retrospective review of Cardiogenic shock patients outcomes","To create an archive of retrospective clinical outcomes (acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock) and compare current versus historical survival rates.","1 Year",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":6,"timePerspective":15,"maskingInfo":13},"PROSPECTIVE","Any patient with cardiogenic shock, whether inpatient or transferred from another facility, treated at the Inova Heart and Vascular Institute shall be included in this registry. This includes adults with and without decision making capacity over the age of 18 years old.\n\nThe primary investigator (PI) will designate the data points to be included in the database in order to assess the efficiency of procedures and protocols in the treatment of cardiogenic shock at the IHVI as administered by the Shock team, to identify relationships between treatment and negative morbidity and mortality outcomes, and to monitor and improve quality of care delivered.","Patients at the IHVI with documented Cardiogenic Shock team intervention for acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock",[19],{"type":20,"name":21,"description":22,"armGroupLabels":13,"otherNames":13},"PROCEDURE","Cardiogenic Shock team activation","Any patient with cardiogenic shock, whether inpatient or transferred from another facility, treated at the Inova Heart and Vascular Institute by the designated Cardiogenic Shock Team.",[24],{"name":25,"affiliation":5,"role":26},"Vanessa Blumer, MD","PRINCIPAL_INVESTIGATOR",[28],{"name":29,"role":30,"phone":31,"phoneExt":13,"email":32},"Bhruga Shah","CONTACT","703-776-2828","bhruga.shah@inova.org",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Inova Fairfax Hospital","RECRUITING","Falls Church","Virginia","22042","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-77.17109,38.88233,{"lat":46,"lon":45},[49,51,53],{"name":50,"role":30,"phone":13,"phoneExt":13,"email":13},"Behnam Tehrani, MD",{"name":52,"role":26,"phone":13,"phoneExt":13,"email":13},"Alex Truesdell, MD",{"name":54,"role":55,"phone":13,"phoneExt":13,"email":13},"Benham Tehrani, MD","SUB_INVESTIGATOR",{"type":57,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100314839",false,"NCT03378739","Inova Cardiogenic Shock Registry (INOVA SHOCK)","Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry)","INOVASHOCK","Inclusion Criteria:\n\n-Patients at the IHVI with documented Cardiogenic Shock team intervention for acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock.\n\nExclusion Criteria:\n\n-Patients under the age of 18 will be excluded.","ALL","18 Years","85 Years",{"count":69,"type":70},3000,"ESTIMATED","OBSERVATIONAL","To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates.\n\nTo collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017.\n\nTo collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella).\n\n• Assess survival at three time points.",[74],"Cardiogenic Shock",[76,77],"cardiogenic","shock","2026-03-12",{"date":80,"type":81},"2026-03-16","ACTUAL",{"date":83,"type":81},"2018-01-01",{"date":85,"type":70},"2099-12-31",{"name":5,"class":6},1]